Quality Assurance of Pharmaceuticals - A Compendium of Guidelines and Related Materials - Volume 1
(1997; 248 pages) [French] View the PDF document
Table of Contents
Open this folder and view contentsIntroduction
Open this folder and view contents1. National drug regulation
Open this folder and view contents2. Product assessment and registration
Open this folder and view contents3. Distribution
Close this folder4. The international pharmacopoeia and related activities
View the documentGuidance for those preparing or commenting on monographs for preparations to be included in The international pharmacopoeia1
View the documentValidation of analytical procedures used in the examination of pharmaceutical materials1
Open this folder and view contentsGeneral guidelines for the establishment, maintenance, and distribution of chemical reference substances1
View the documentGeneral recommendations for the preparation and use of infrared spectra in pharmaceutical analysis1
View the documentList of available International Chemical Reference Substances1
View the documentList of available International Infrared Reference Spectra1
Open this folder and view contents5. Basic tests
Open this folder and view contents6. Laboratory services
Open this folder and view contents7. International trade in pharmaceuticals
Open this folder and view contents8. Counterfeit products
Open this folder and view contents9. Training
View the documentSelected WHO publications of related interest
View the documentBack cover
 

List of available International Infrared Reference Spectra1

1WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirty-fourth Report. Geneva, World Health Organization, 1996 (WHO Technical Report Series, No. 863).

International Infrared Reference Spectra are established on the advice of the WHO Expert Committee on Specifications for Pharmaceutical Preparations. Full-scale reproductions of spectra produced from authenticated material on a suitable instrument are supplied for use in identification tests described in the specifications for quality control of drugs published in The international pharmacopoeia or proposed in draft monographs.

Precise instructions for the preparation of spectra are given on the label of each reference spectrum. All International Infrared Reference Spectra are distributed together with a document giving further details on the use of such spectra, entitled “General recommendations for the preparation and use of infrared spectra in pharmaceutical analysis”.

Orders for International Infrared Reference Spectra should be sent to:

WHO Collaborating Centre for Chemical Reference Substances
Apoteksbolaget AB
Centrallaboratoriet
S-105 14 Stockholm
Sweden
Telex: 115 53 APOBOL S
Fax: 46 8 740 60 40

The following International Infrared Reference Spectra are currently available from the Centre:1

1 Spectra for several other substances are still being validated and are not yet available for distribution.

aceclidine salicylate
acetazolamide
allopurinol
amitriptyline hydrochloride
ampicillin trihydrate

benzylpenicillin potassium
biperiden
biperiden hydrochloride
bupivacaine hydrochloride

caffeine (anhydrous)
chlorphenamine hydrogen maleate clofazimine
cloxacillin sodium
colchicine
cytarabine

dextromethorphan hydrobromide
diazepam
dicolinium iodide
dicoumarol
diethylcarbamazine dihydrogen citrate
diphenoxylate hydrochloride

erythromycin ethylsuccinate
erythromycin stearate
etacrynic acid
ethionamide
ethosuximide

furosemide

gallamine triethiodide
glibenclamide

haloperidol hydrochlorothiazide

ibuprofen
imipramine hydrochloride
indometacin
isoniazid

lidocaine
lidocaine hydrochloride
lindane

metronidazole
miconazole nitrate

niclosamide
nicotinamide
noscapine

oxamniquine

papaverine hydrochloride
phenobarbital
phenoxymethylpenicillin calcium
phenytoin
primaquine phosphate
propylthiouracil
protionamide
pyrimethamine

salbutamol
salbutamol sulfate
sulfadimidine
sulfadoxine
sulfamethoxazole
sulfamethoxypyridazine

tiabendazole
trihexyphenidyl hydrochloride
trimethoprim
verapamil hydrochloride

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: November 5, 2014